UnknownNot Applicable

Endothelial Changes in Pseudoexfoliation Syndrome

100 participantsStarted 2022-02-01

Plain-language summary

this study aimed to evaluate the corneal endothelial cell changes before and after phacoemulsification in pseudoexfoliative patients relative to healthy adults.

Who can participate

Age range50 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient age is above50 years.
✓. Patient with nuclear cataract grade II, III.
✓. Clear cornea with no evidence of endothelial disease.
✓. Endothelial cell density more than 1000\\mm2.
✓. Normal anterior chamber depth and dilatable pupil.
✓. No active ocular disease or inflammation.
✓. Pseudoexfoliative patients.

Exclusion criteria

✕. History of previous trauma, intraocular surgery or ocular surface infection in recent two weeks.
✕. Presence of any corneal opacity, endothelial disease, scarring or dystrophies.
✕. Pseudoexfoliative glaucoma.
✕. Patients age below 50 years.
✕. Endothelial cell count less than 1000\\mm2.

What they're measuring

Study of corneal endothelial changes in pseudoexfoliation syndrome

Timeframe: Baseline

Trial details

NCT IDNCT05194891

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-02

Contact for this trial

Shymaa Ahmed, Doctor

+20 106 319 4646 shymaa.sabet@yahoo.com

View on ClinicalTrials.gov More Endothelial Cell Loss, Corneal trials